Company Comparison
Carmat vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Carmat | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Vélizy-Villacoublay, France | South San Francisco, California |
| Founded | 2008 | 2006 |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | €63M | — |
| Valuation | — | — |
What They Build
Carmat
Carmat develops artificial heart devices designed to replace the function of a failing heart in patients with end-stage heart failure.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Sector Overlap
Both Carmat and 23andMe operate in Biotech.
Browse all Biotech companies →